Aminex Therapeutics, Inc. — Form D
Aminex Therapeutics, Inc. of Kenmore, WA, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-01. The offering totals $14.2M, of which $8.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-06-01
- Form: D
- Accession: 0001613386-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.2M
- Amount sold: $8.3M
- Remaining: $5.9M
- Investors: 96
- Date of first sale: 2018-05-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-313679
Issuer
- Name: Aminex Therapeutics, Inc.
- CIK: 0001613386
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Address: 6830 NE Bothell Way Ste C139, Kenmore, WA, 98028
- Phone: 425-286-4222
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Thomas Graham | Director | London, X0 |
| Thomas Graham | Executive Officer | London, X0 |
| Jeffrey Miller | Director | San Mateo, CA |
| Deyaa Adib | Director | Kenmore, WA |
| James Skaggs | Director | Kenmore, WA |
| James Skaggs | Executive Officer | Kenmore, WA |
| Mark Burns | Director | Kenmore, WA |
| Mark Burns | Executive Officer | Kenmore, WA |
| David Meeks | Director | Kenmore, WA |
| Don Dyer | Director | Kenmore, WA |
| Rhonda Rhyne | Director | Kirkland, WA |
| Larry Richards | Executive Officer | Kenmore, WA |
| Roger Ulrich | Director | Kenmore, WA |
| Jeff Miller | Director | Homestead, PA |
| Stacy Hock | Director | Kenmore, WA |
| John Rosling | Director | Kirkland, WA |
| Donald Mowat | Director | Kirkland, WA |
Other filings by this issuer (5)
More